The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
Clinical trial NCT07457125 · RECRUITING
Trial details
- NCT number
- NCT07457125
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-12-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.